NEW YORK (GenomeWeb News) — Novartis has licensed Caliper Life Sciences’ intellectual property covering non-invasive optical imaging methods, Caliper said today.
 
Under the multi-year agreement, the drug maker will use Caliper’s Optical Imaging patent suite, which includes imaging systems, reagents, related applications, and methods and services, Caliper said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.